FDA Application
-
NDC Search Results on Active Ingredient: doxorubicin
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | 0338-9581-02 | Baxter Healthcare Corporation | HUMAN PRESCRIPTION DRUG | Unapproved drug for use in drug shortage | |
| DOXORUBICIN HYDROCHLORIDE | 63323-883-05 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-3034-20 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 25021-207-51 | Sagent Pharmaceuticals | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 63323-883-30 | Fresenius Kabi USA, LLC | ANDA063277 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-683-25 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-60 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-4026-25 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 16714-001-01 | Northstar RxLLC | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0338-0063-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-3031-20 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9371-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9084-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 49315-009-07 | Zydus Lifesciences Limited | ANDA212299 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 49315-008-03 | Zydus Lifesciences Limited | ANDA212299 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9090-01 | Hikma Pharmaceuticals USA Inc. | ANDA062975 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9092-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0069-4037-01 | Pfizer Laboratories Div Pfizer Inc | NDA050629 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 70121-1218-1 | Amneal Pharmaceuticals LLC | ANDA208888 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-682-35 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 70710-1531-1 | Zydus Pharmaceuticals USA Inc. | ANDA212299 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0338-0067-01 | Baxter Healthcare Corporation | NDA050718 | HUMAN PRESCRIPTION DRUG | NDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9091-01 | Hikma Pharmaceuticals USA Inc. | ANDA064097 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 43598-283-35 | Dr. Reddy's Laboratories Inc | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 68083-248-01 | Gland Pharma Limited | ANDA209825 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9277-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 45963-733-55 | Actavis Pharma, Inc. | ANDA203622 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 16714-856-01 | NorthStar RxLLC | ANDA208657 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 62756-827-40 | Sun Pharmaceutical Industries, Inc. | ANDA091418 | HUMAN PRESCRIPTION DRUG | ANDA |
| DOXORUBICIN HYDROCHLORIDE | 0143-9093-01 | Hikma Pharmaceuticals USA Inc. | ANDA062921 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-78 |
-
